Navigation Links
Bioniche Reports the Passing of its Board Chair
Date:4/18/2008

ted annually to the Bioniche employee who best epitomizes the Bioniche spirit - whether at work or in the community.

A new Chair will be appointed at the Board's next quarterly meeting in early May.

About Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 200 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. Bioniche has been named one of Canada's Top Ten Life Sciences Companies for 2008. For more information, please visit http://www.Bioniche.com.

Except for historical information, this news release may contain forward-looking statements that reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process, and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.


'/>"/>
SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bioniche Converts a Portion of its Debt to Equity
2. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
3. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
4. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
5. Bioniche Reports Fiscal 2008 Second Quarter
6. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
7. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Reports Fiscal 2008 First Quarter
10. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
11. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... ... Anthony J. Tantillo, Esq., Attorney from William Mattar Law Offices, is ... a row. Through nomination, research and strategic evaluation processes, Tantillo continues to impress ... York, Tantillo is a Buffalo State College graduate of 1998. Tantillo went on ...
(Date:9/1/2015)... ... 01, 2015 , ... September is Baby Safety Month, and Lightning Labels ... to keep little ones' safety top of mind at all times. , Sponsored by ... According to the JPMA's Baby Safety Zone website, this year's theme is A Room ...
(Date:8/31/2015)... ... September 01, 2015 , ... AthleticTraining.com, provider of CEUs ... hours of new premium on-demand video Evidence Based Practice courses ... before 2014 must complete 50 CEUs before December 31, 2015, which must include ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Sculpted Contours Luxury ... Atlanta’s Women of Power and Influence by Modern Luxury’s The Atlantan Magazine. ... business as well as Kathy King. Her idea and vision to bring to ...
(Date:8/31/2015)... Santa Rosa Beach, FL (PRWEB) , ... August 31, 2015 , ... ... Southern family of companies – has teamed up with fellow South Walton property ... organization focused on eliminating extreme poverty in remote parts of the world. The two ...
Breaking Medicine News(10 mins):Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3
... Mass., Oct. 30 Repligen Corporation,(Nasdaq: RGEN ) ... Walter C. Herlihy, Ph.D., will host a conference call,and ... EST, to report,second quarter fiscal year 2009 financial results ... This call is being webcast by Thomson/CCBN and can ...
... Prices, According To New Data ... from Arlington Medical Resources, MALVERN, Penn., Oct. 30 ... the pharmaceutical and,diagnostic imaging industries, finds that echinocandins show growth in ... courses,in the January - June 2008 time period compared to 9 ...
... Visit Washington D.C. to Rally Residents to Eat Right, Move ... More and Milk Their ... by,the ups and downs of different fad diets -- which seem to ... success has been,slim. Two out of three Americans -- including 22% of ...
... Mid-Atlantic Region, ATLANTA, Oct. 30 AmeriCare ( ... the opening of its,latest franchises serving Howard, Montgomery, and ... states in the union, Maryland is in the,top 20 ... Marylanders is over the,age of 60. AmeriCare of Maryland ...
... MIAMI, Oct. 30 Physicians Healthcare,Management Group, Inc. (Phyhealth) ... in partnership with physicians,today announced that its board of ... to 5% of the Company,s outstanding Common Stock., ... at the market price.,The purchases will be made at ...
... MED ) announced today that it will release third quarter ... 30, 2008 on,Thursday, November 6, 2008. The Company will hold ... Thursday, November 6, at 11:00 a.m. ET., Interested parties ... or can listen via a live Internet web cast, which ...
Cached Medicine News:Health News:Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST 2Health News:Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST 3Health News:Echinocandins Show Growth Among All Antifungal Classes 2Health News:Echinocandins Show Growth Among All Antifungal Classes 3Health News:Message to Washington D.C. Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Washington D.C. Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Caregiving Company AmeriCare Adds Franchise in Maryland 2Health News:Phyhealth Announces Stock Buyback Program 2Health News:Phyhealth Announces Stock Buyback Program 3Health News:Medifast, Inc. to Announce Third Quarter of Fiscal Year 2008 Financial Results on Thursday, November 6, 2008 2
(Date:8/31/2015)...  Ascendant Solutions, Inc. (Pink Sheets: ASDS ) ... subsidiary, Dougherty,s Holdings, has acquired Springtown Drug (" ... Springtown, Texas , just north of ... pharmacy has provided retail prescriptions, healthcare products and gifts ... . The Springtown ...
(Date:8/31/2015)... Pa. , Aug. 31, 2015 The ... reversed statewide since Pennsylvania State ... life-saving drug kits, naloxone. Heroin and opioid ... Pennsylvania , killing more individuals than ... approximately 2,400 Pennsylvanians died from a drug overdose. ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
Breaking Medicine Technology:Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 2Ascendant Solutions, Inc. Announces Completion of Fifth Pharmacy Acquisition by Its Dougherty's Holdings Subsidiary 3Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... June 9 Halozyme Therapeutics,Inc. (Nasdaq: ... products targeting the extracellular matrix, today,announced new ... mellitus program at,the American Diabetes Association,s 68th ... company,s proprietary recombinant human,hyaluronidase enzyme (rHuPH20) with ...
... Pivotal Study Highlighted at Recent Arizona Alzheimer,s ... Consortium Annual Conference in Phoenix -, PHOENIX and ... Health Research Institute today announced that they are,actively enrolling patients ... treatment of Alzheimer,s disease. The study will,evaluate the safety and ...
Cached Medicine Technology:Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 2Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 3Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 4Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability 5Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Banner Alzheimer's Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3